Advertisement
Ginkgo Bioworks Acquires Biotechnology Company Circularis For Undisclosed Terms
(RTTNews) - Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, announced Tuesday the tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.
When circularized, RNA is much longer-lived in cells, improving its robustness as a potential therapeutic modality. The Circularis platform also allows ultra-high-throughput screening of promoters and other enhancers.
The Circularis platform strengthens Ginkgo's platform for development of cell and gene therapies, providing the capability to rapidly identify novel promoters with appropriate strength and tissue-specificity designed into customer specific delivery modalities.
read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets
Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews
|
vor 606 Tagen
Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins
Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.
RTTNews
|
vor 622 Tagen
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges
Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews
|
vor 698 Tagen
Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products
Brazilian agricultural biologicals company Agrivalle announced Friday a new partnership with Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity.
RTTNews
|
vor 731 Tagen
NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides
Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.
RTTNews
|
vor 1055 Tagen
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal
Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews
|
vor 1232 Tagen
Australian Market Maintains Early Losses In Mid-market
The Australian stock market is maintaining the early loses after slipping briefly in mid-market trading on Tuesday, extending the losses in the previous session, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling to near the 8,600 level, with a mixed performance across most sectors ahead of the domestic interest rate decision later in the day.
RTTNews
|
vor 1Std 46 Minuten
Asian Markets Track Wall Street Lower
Asian markets are mostly lower on Tuesday, following the negative cues from Wall Street overnight, as traders remain cautious and are not willing to take any significant positions ahead of monetary policy announcement by the US Fed tomorrow. With the Fed widely expected to lower interest rates by another 25 basis points, traders are likely to pay close attention to the accompanying statement.
RTTNews
|
vor 2Std 7 Minuten
